Immunotherapy Is Associated with a Lower Risk of Relapse in Lung Cancer Survivors

OKDIARIO

Factuality

Ownership

Patients with lung cancer treated with immunotherapy or targeted therapies had a significantly lower incidence of developing second primary cancers, according to a study led by the Spanish Lung Cancer Group (GECP). The study also highlights that patients with a history of smoking were 60% more at risk of developing a new type of ... Continue reading "Immunotherapy is associated with a lower risk of relapse in lung cancer survivors"

focoinformativo.site

Factuality

Ownership

Patients with lung cancer treated with immunotherapy or targeted therapies have a lower risk of developing a second primary cancer than those receiving chemotherapy, according to a study by the Spanish Lung Cancer Group (GECP). The study, published in the scientific journal The Lancet Regional Health Europe, is based on data from [...] The entry Patients with immunotherapy and targeted therapies have less risk of a new tumor was first published …

redaccionmedica.com

Factuality

Ownership

A study led by the Spanish Lung Cancer Group (GECP) and published in The Lancet Regional Health Europe reveals that lung cancer patients treated with immunotherapy or targeted therapies have a lower risk of developing a second primary cancer compared to those receiving chemotherapy The work, one of the largest in Europe, is based on data from the GECP Spanish Toracic Tumor Registry (RTT) and includes an analysis of 20,574 patients diagnosed with…

diarioestrategia.cl

Factuality

Ownership

Patients with lung cancer treated with immunotherapy and targeted therapy had a significantly lower incidence of developing second primary cancers, according to a study led by the Spanish Lung Cancer Group (GECP), which also affected that patients with a history of previous smoking had a 60% higher risk of developing a second tumor and those who continued to smoke also showed a significantly higher risk.

informacion.es

Factuality

Ownership

Thanks to advances in the face of cancer, more and more surviving patients live longer. But having had a primary cancer does not free you from being able to suffer a secondary tumor, which originates from scratch in another part of the body, with cells and characteristics different from the initial one. It is an infrequent situation but that is becoming more and more relevant, as the survival rates increase.